Caitlin Kontulis
Finanzdirektor/CFO bei PHIO PHARMACEUTICALS CORP.
Vermögen: 7 769 $ am 31.05.2024
Aktive Positionen von Caitlin Kontulis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Verwaltungsdirektor | - | - |
| Finanzdirektor/CFO | - | - | |
| Unternehmenssekretär | - | - |
Karriereverlauf von Caitlin Kontulis
Ehemalige bekannte Positionen von Caitlin Kontulis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 18.04.2011 | - |
Ausbildung von Caitlin Kontulis
| Bryant University | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Comptroller/Controller/Auditor | 1 |
| Chief Administrative Officer | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Börse
- Insiders
- Caitlin Kontulis
- Erfahrung
